The global forensic technologies and services market was valued at USD 7.85 billion in 2025. The market is projected to grow from USD 8.6 billion in 2026 to USD 17.27 billion by 2034, exhibiting a compound annual growth rate of 9.11% during the forecast period. Contrive Datum Insights presents this information in its report titled "Forensic Technologies And Services Market Size, Share & Industry Analysis, By Type (Capillary Electrophoresis, Polymerase Chain Reaction (PCR), Next Generation Sequencing (NGS), Rapid DNA Analysis, Automated Liquid Handling Technology, Microarrays, Others), Location (Laboratory Forensic Technology, Portable Forensic Technology), Application (Judicial/Law Enforcement, Biodefense & Biosurveillance, Pharmacogenetics, Others), Offering (Consumables & Reagents, Instruments, Services, Software & Data Analysis Solutions), End user (Forensic Laboratories, Law Enforcement Agencies & Crime Investigation Departments, Hospitals & Diagnostic Centers, Academic & Research Institutes), and Regional Forecast, 2026-2034".
Forensic technologies and services cover the instruments, reagents, software and laboratory and field services used to collect, process and interpret biological and trace evidence for criminal investigation, biodefense surveillance and pharmacogenetic testing. The category spans laboratory-based platforms such as capillary electrophoresis and next generation sequencing alongside portable field devices, plus the consumables, case-management software and analytical services that accompany them. Buyers include public and private forensic laboratories, law enforcement and crime investigation departments, hospitals and diagnostic centers, and academic and research institutes.
Rising caseload backlogs pushing laboratory automation adoption
Rising caseload backlogs pushing laboratory automation adoption is the largest single contributor to the market's growth over the forecast period, and the study rates its impact high. Against a market growing at 9.11% a year, the type lines exposed to it move fastest: Next Generation Sequencing (NGS) compounds at 14.58%, taking its share of revenue from 14.01% to 22% and its value from USD 1.1 billion to USD 3.8 billion.
On the upside, the study's bull case assumes assumes faster laboratory adoption of next generation sequencing and rapid DNA platforms alongside sustained public safety and biosurveillance funding across major markets, which would take 2034 revenue to USD 19.69 billion against the USD 17.27 billion base case.
On the downside, assumes tighter public laboratory budgets and slower accreditation approvals delay platform upgrades and reagent volume growth across major markets, which would hold 2034 revenue to USD 15.46 billion. Capillary Electrophoresis, which carries 31.97% of 2025 revenue, already grows at only 7.42% against the market's 9.11%, so the largest part of the base is also its slowest.
Where the Competition Actually Sits
The type axis, not the regional one, is what divides the field. Capillary Electrophoresis is the volume position, 31.97% of 2025 revenue at USD 2.51 billion, holding 28.02% through 2034, and it is defended by scale. Next Generation Sequencing (NGS) is the growth position at 14.58%, and it is open. Strength in one does not carry into the other.
Additional Findings
| Segment | Led 2025 by | Share & value | Fastest-growing |
|---|---|---|---|
| Location | Laboratory Forensic Technology | 77.96% · USD 6.12 billion | Portable Forensic Technology 13.78% |
| Application | Judicial/Law Enforcement | 62.04% · USD 4.87 billion | Pharmacogenetics 12.72% |
| Offering | Consumables & Reagents | 37.96% · USD 2.98 billion | Software & Data Analysis Solutions 15.15% |
| End user | Forensic Laboratories | 43.95% · USD 3.45 billion | Hospitals & Diagnostic Centers 11.37% |
- North America was the largest region in 2025, holding 37.83% of global revenue at USD 2.97 billion and reaching USD 5.87 billion by 2034.
- Asia Pacific takes a rising share of global revenue over the forecast period, from 23.18% in 2025 to 29.01% in 2034, with revenue growing from USD 1.82 billion to USD 5.01 billion.
- At 5.86% of 2025 revenue and 5.5% by 2034, Middle East and Africa is the smallest region throughout.
- By type, the largest line in 2025 was Capillary Electrophoresis, at 31.97% of revenue and USD 2.51 billion.
- Next Generation Sequencing (NGS) is projected to grow at 14.58% over the forecast period, the fastest of any type line.
- The United States is the largest single country market at USD 2.32 billion in 2025, 29.55% of global revenue.
The study covers five axes, by type, and by location, application, offering and end user, reporting revenue and a growth rate for every line in every year from 2020 to 2034, with bear, base and bull scenarios on the headline total at USD 15.46 billion and USD 19.69 billion by 2034. Country-level detail is given for all five regions, together with the competitive landscape and the research methodology. Delivered as a PDF; request a free sample to review it.